Clinical Trial Update: A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 study comparing the effect of double doses of two long-acting insulin therapies in adults with Type 2 Diabetes Mellitus completed with posted results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Long-acting insulin therapies (two formulations included in study)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2018-04-20